US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain Jan 15 Written by Jonathan Karush Jonathan Karush Previous Previous Opinion: Why CT must tackle the PBM problem. Next Next Patients Not PBMs Connecticut Formed to Push for Prescription Drug Transparency at the Pharmacy Counter
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain Jan 15 Written by Jonathan Karush Jonathan Karush
